研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

癌症中的 WNT5A:一项泛癌症分析揭示了其诊断和预后生物标志物的潜力。

WNT5A in Cancer: A Pan-Cancer Analysis Revealing Its Diagnostic and Prognostic Biomarker Potential.

发表日期:2024 Jul
作者: Mutaz Mohammed Abdallah, Mawada Yahia, Yousra Tagelsir Ahmed, Mohamed Alfaki
来源: GENES & DEVELOPMENT

摘要:

无翼相关整合位点家族(WNT)信号通路对于肿瘤的进展和发展至关重要。它与 WNT 通路失调产生的各种肿瘤有关; WNT5A 是 WNT 家族的成员,与致癌作用有关,表现出致癌或肿瘤抑制作用。该研究调查了该基因如何影响某些类型的癌症。 该研究旨在评估WNT5A基因作为各种类型癌症的诊断生物标志物的潜在预后意义。我们使用各种生物信息学数据库,包括GEPIA(基因表达谱交互分析)、TIMER2(肿瘤)在泛癌分析中研究了WNT5A基因表达免疫估计资源,版本 2)、阿拉巴马大学伯明翰癌症数据分析门户 UACLAN 数据库、Kaplan-Meier (K-M) 绘图仪、cBioPortal 和基因集癌症分析 (GSCA)。我们的目的是深入了解 WNT5A 在各种肿瘤中的表达及其与免疫浸润、总体生存和遗传变化的关系。公共数据集验证了 WNT5A 在肺鳞状细胞癌 (LUSC) 和胃腺癌 (STAD) 样本中的表达。WNT5A 泛癌分析在两种癌症类型中高表达,包括 STAD 和 LUSC。此外,TIMER 结果显示 WNT5A 与 LUSC 和 STAD 中的免疫细胞浸润呈正相关。生存分析表明,LUSC 癌症表现出更好的总体生存率,而 STAD 癌症的总体生存水平较低,这意味着 STAD 癌症类型的预后较差。此外,突变分析显示,WNT5A 基因在 1.4% 的病例中发生突变,其中大多数改变是缺失和扩增。WNT5A 基因在包括 LUSC 和 STAD 在内的许多恶性肿瘤中高表达,表明它可以用作诊断生物标志物。这项研究显示了 LUSC 和 STAD 中 WNT5A 表达与免疫细胞丰度之间的关系。我们对该基因的泛癌分析是同类中的首次,它将为未来的研究、综合调查和湿实验室实验提供信息。版权所有 © 2024,Abdallah 等人。
The wingless-related integration site family (WNT) signaling pathway is critical for tumor progression and development. It is associated with various neoplasms produced by WNT pathway deregulation; WNT5A, a member of the WNT family, has been linked to carcinogenesis, exhibiting either oncogenic or tumor-suppressive effects. The study investigates how the gene affects certain types of cancer. The study aimed to evaluate the potential prognostic significance of WNT5A genes as diagnostic biomarkers for various types of cancer.We investigated WNT5A gene expression in a pan-cancer analysis using various bioinformatics databases, including GEPIA (Gene Expression Profiling Interactive Analysis), TIMER2 (Tumor Immune Estimation Resource, Version 2), the University of Alabama at Birmingham Cancer Data Analysis Portal UACLAN databases, the Kaplan-Meier (K-M) plotter, cBioPortal, and Gene Set Cancer Analysis (GSCA). We aimed to gain insight into the expression of WNT5A in various tumors and its relationship with immune infiltration, overall survival, and genetic changes. Public datasets validated WNT5A expression in lung squamous cell carcinoma (LUSC) and stomach adenocarcinoma (STAD) samples.WNT5A pan-cancer analysis was highly expressed in two cancer types, including STAD and LUSC. Additionally, TIMER results showed a positive association of WNT5A with immune cell infiltration in LUSC and STAD. Survival analysis indicated that LUSC cancer exhibits better overall survival, while STAD has lower overall survival levels, which means a poor prognosis in the STAD cancer type. Furthermore, mutation analysis revealed that the WNT5A gene was mutated in 1.4% of cases, with most alterations being deletions followed by amplifications.The WNT5A gene's high expression in many malignancies, including LUSC and STAD, suggests it could be used as a diagnostic biomarker. This study shows a relationship between WNT5A expression and immune cell abundance in LUSC and STAD. Our pan-cancer analysis of this gene is the first of its type, and it will inform future research, comprehensive investigation, and wet lab experiments.Copyright © 2024, Abdallah et al.